Home › NDC Lookup › RxCUI directory › RxCUI 308976

Carbamazepine 20 MG/ML Oral Suspension — RxCUI 308976

RxNorm drug concept · Semantic clinical drug
RxCUI 308976 Semantic clinical drug · SCD ● Current RxNorm concept 13 FDA products 25 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI308976
Official nameCarbamazepine 20 MG/ML Oral Suspension
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ascarbamazepine 100 MG per 5 ML Oral Suspension; carBAMazepine 100 MG in 5 mL Oral Suspension; carbamazepine 200 MG per 10 ML Oral Suspension
FDA products mapped13
Package NDCs mapped25
Reported Medicaid activity (SDUD)80,285 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Carbamazepine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It treats certain seizures in epilepsy and the severe facial nerve pain of trigeminal neuralgia. The brand Equetro is also used for manic or mixed episodes in bipolar I disorder. I...
  • Take it by mouth exactly as prescribed. Many forms are taken with meals, and extended-release forms are usually twice a day. Carbatrol and Equetro capsules can be opened onto soft...
  • Dizziness, drowsiness, unsteadiness, nausea and vomiting are most common, especially at the start. Be careful driving until you know how it affects you. Call your doctor if they do...
  • Call for any rash, blisters or mouth sores, especially with fever. Also report fever, sore throat, easy bruising or bleeding, yellow skin or eyes, swelling of the face or lips, or...
📖 Read our full Carbamazepine guide →

🕸️ Concept Web — How Carbamazepine 20 MG/ML Oral Suspension Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Carbamazepine 20 MG/ML Oral Suspension RxCUI 308976

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Carbamazepine 2002
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Tegretol 203029
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Carbamazepine Oral Suspension 371259
    • Carbamazepine Oral Liquid Product 1155759
    • Carbamazepine Oral Product 1155760
    • Carbamazepine Oral Suspension [Tegretol] 365997
    • Tegretol Oral Liquid Product 1180854
    • Tegretol Oral Product 1180855
    • Oral Suspension 316969
    • Oral Liquid Product 1151137
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Carbamazepine 20 MG/ML 315564
    • Carbamazepine 20 MG/ML Oral Suspension [Tegretol] 308971
    • Carbamazepine 20 MG/ML [Tegretol] 485053

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Carbamazepine 20 MG/ML SCDC · 315564
  • Carbamazepine Oral Suspension SCDF · 371259
  • Carbamazepine Oral Liquid Product SCDG · 1155759
  • Carbamazepine Oral Product SCDG · 1155760

Brand-Name Concepts

  • Carbamazepine 20 MG/ML Oral Suspension [Tegretol] SBD · 308971
  • Carbamazepine 20 MG/ML [Tegretol] SBDC · 485053
  • Carbamazepine Oral Suspension [Tegretol] SBDF · 365997
  • Tegretol Oral Liquid Product SBDG · 1180854
  • Tegretol Oral Product SBDG · 1180855
  • Tegretol BN · 203029

📦 FDA Products & Package NDCs

13 products · 25 package NDCs
25 package NDCs map to RxCUI 308976 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
17856-4047-01 10 mL in 1 CUP (17856-4047-1) Carbamazepine Atlantic Biologicals Corps 2015-04-28
51672-4005-01 100 TABLET in 1 BOTTLE (51672-4005-1) Carbamazepine Sun Pharmaceutical Industries, Inc. 1996-10-03
51672-4005-02 500 TABLET in 1 BOTTLE (51672-4005-2) Carbamazepine Sun Pharmaceutical Industries, Inc. 1996-10-03
51672-4005-03 1000 TABLET in 1 BOTTLE (51672-4005-3) Carbamazepine Sun Pharmaceutical Industries, Inc. 1996-10-03
51672-4041-00 10 BLISTER PACK in 1 CARTON (51672-4041-0) / 10 TABLET, CHE... Carbamazepine Sun Pharmaceutical Industries, Inc. 2000-10-24
51672-4041-01 100 TABLET, CHEWABLE in 1 BOTTLE (51672-4041-1) Carbamazepine Sun Pharmaceutical Industries, Inc. 2000-10-24
51672-4041-02 500 TABLET, CHEWABLE in 1 BOTTLE (51672-4041-2) Carbamazepine Sun Pharmaceutical Industries, Inc. 2000-10-24
51672-4041-09 5 BLISTER PACK in 1 CARTON (51672-4041-9) / 10 TABLET, CHEW... Carbamazepine Sun Pharmaceutical Industries, Inc. 2000-10-24
51672-4047-04 1 BOTTLE in 1 CARTON (51672-4047-4) / 450 mL in 1 BOTTLE Carbamazepine Sun Pharmaceutical Industries, Inc. 2025-08-15
51672-4050-01 100 TABLET, CHEWABLE in 1 BOTTLE (51672-4050-1) Carbamazepine Sun Pharmaceutical Industries, Inc. 2024-03-20
51672-4123-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (51672-4123-1) Carbamazepine Sun Pharmaceutical Industries, Inc. 2009-03-31
51672-4123-03 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (51672-4123-3) Carbamazepine Sun Pharmaceutical Industries, Inc. 2009-03-31
51672-4123-06 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (51672-4123-6) Carbamazepine Sun Pharmaceutical Industries, Inc. 2009-03-31
51672-4124-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (51672-4124-1) Carbamazepine Sun Pharmaceutical Industries, Inc. 2009-03-31
51672-4124-03 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (51672-4124-3) Carbamazepine Sun Pharmaceutical Industries, Inc. 2009-03-31
51672-4124-06 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (51672-4124-6) Carbamazepine Sun Pharmaceutical Industries, Inc. 2009-03-31
51672-4125-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (51672-4125-1) Carbamazepine Sun Pharmaceutical Industries, Inc. 2009-03-31
51672-4125-03 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (51672-4125-3) Carbamazepine Sun Pharmaceutical Industries, Inc. 2009-03-31
51672-4125-06 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (51672-4125-6) Carbamazepine Sun Pharmaceutical Industries, Inc. 2009-03-31
62135-0802-24 2 TRAY in 1 BOX (62135-802-24) / 10 PACKAGE in 1 TRAY / 5 m... Carbamazepine Chartwell RX, LLC 2024-05-28
62135-0802-53 450 mL in 1 BOTTLE (62135-802-53) Carbamazepine Chartwell RX, LLC 2023-12-01
62135-0867-24 2 TRAY in 1 BOX (62135-867-24) / 10 PACKAGE in 1 TRAY / 10... Carbamazepine Chartwell RX, LLC 2024-05-28
68999-0802-24 2 TRAY in 1 BOX (68999-802-24) / 10 CUP in 1 TRAY / 5 mL in... Carbamazepine Chartwell Governmental & Specialty RX, LLC. 2025-10-15
68999-0867-24 2 TRAY in 1 BOX (68999-867-24) / 10 CUP in 1 TRAY / 10 mL i... Carbamazepine Chartwell Governmental & Specialty RX, LLC. 2025-10-15
70954-0240-10 1 BOTTLE in 1 CARTON (70954-240-10) / 450 mL in 1 BOTTLE Carbamazepine ANI Pharmaceuticals, Inc. 2022-10-06
Observed labelers: Sun Pharmaceutical Industries, Inc. (18) · Chartwell RX, LLC (3) · Chartwell Governmental & Specialty RX, LLC. (2) · ANI Pharmaceuticals, Inc. (1) · Atlantic Biologicals Corps (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.